Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29596029

Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 May 10
First author
Wu YL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Wu YL
      type
      Author
    2. name
      Yang JC
      type
      Author
    3. name
      Kim DW
      type
      Author
    4. name
      Lu S
      type
      Author
    5. name
      Zhou J
      type
      Author
    6. name
      Seto T
      type
      Author
    7. name
      Yang JJ
      type
      Author
    8. name
      Yamamoto N
      type
      Author
    9. name
      Ahn MJ
      type
      Author
    10. name
      Takahashi T
      type
      Author
    11. name
      Yamanaka T
      type
      Author
    12. name
      Kemner A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Wu YL
      type
      Author
    2. name
      Yang JC
      type
      Author
    3. name
      Kim DW
      type
      Author
    4. name
      Lu S
      type
      Author
    5. name
      Zhou J
      type
      Author
    6. name
      Seto T
      type
      Author
    7. name
      Yang JJ
      type
      Author
    8. name
      Yamamoto N
      type
      Author
    9. name
      Ahn MJ
      type
      Author
    10. name
      Takahashi T
      type
      Author
    11. name
      Yamanaka T
      type
      Author
    12. name
      Kemner A
      type
      Author
    bibliography ids
    1. nci-bib-d65391e1085d143bd26c9e2b
    book metadata
    content sha256
    d27a6021046ed4a22c8786111720bad748c7e95ef2528c2cf926e4635d7f261d
    document type
    citation
    dois
    1. 10.1200/JCO.2017.75.5587
    electronic publication date
    display
    2018 Mar 29
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29596029
    immutable id
    pubmed:29596029@d27a6021046ed4a22c8786111720bad748c7e95ef2528c2cf926e4635d7f261d
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    14
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1405-1411
    volume
    36
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29596029
      provenance
      batch id
      ec9444d0f4cade22eb9f
      provider
      NCBI PubMed ESummary
      record sha256
      5cfd83ef81f674a66de64c739fe6ed76ec6469a8ec63dd66813a453f9dc85e57
      response sha256
      6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
      retrieved at
      2026-09-09T23:47:30.975610+00:00
      publication date
      display
      2018 May 10
      precision
      day
      year
      2018
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29596029/
      title
      Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

      Preserved source evidence · Not medical advice